CHO Cell Line Development Service

Tech Support Documents
CHO Cell Line Development Service CHO Cell Line Development Service CHO Cell Line Development Service CHO Cell Line Development Service CHO Cell Line Development Service
 

Get the option to either outsource your CHO cell line development program (partially orentirely) to Sartorius or access our cell line development technology for your in-house development. In both options, you would be get access to an advance cell line development platform that is industry recognized and regulatory proven.

With outsourcing, Sartorius would be your extended laboratory bench and trusted drug development partner. While with licensing our technology, you would have access to a ready-to-use platform, avoiding lengthy optimization steps and seamlessly rebuild our platform in your labs.

In 2026, we have upgraded our CLD technology with the launch of our novel genetically engineered CHO host cell line with up to 2-fold and 3-fold increase in titer and cell-specificproductivity respectively across different protein molecule types. This cell line was rationally designed through proteomic profiling and CRISPR-mediated gene editing to deliver a more productive host while maintaining product quality and robust stability.

See more Products below
*Custom/bulk order quotes are provided within 72 hours of request.
CHO Cell Line Development Service
CHO Cell Line Development Service

Get the option to either outsource your CHO cell line development program (partially orentirely) to Sartorius or access our cell line development technology for your in-house development. In both options, you would be get access to an advance cell line development platform that is industry recognized and regulatory proven.

With outsourcing, Sartorius would be your extended laboratory bench and trusted drug development partner. While with licensing our technology, you would have access to a ready-to-use platform, avoiding lengthy optimization steps and seamlessly rebuild our platform in your labs.

In 2026, we have upgraded our CLD technology with the launch of our novel genetically engineered CHO host cell line with up to 2-fold and 3-fold increase in titer and cell-specificproductivity respectively across different protein molecule types. This cell line was rationally designed through proteomic profiling and CRISPR-mediated gene editing to deliver a more productive host while maintaining product quality and robust stability.

Item No.:
CHO_CLD_Service

Overview

Specifications

Choose your product

Products (5)

The purpose of the Technology License Research Package is to evaluate the expression of your target molecule(s) using our CHO cell line development technology in-house for both feasibility and | or manufacturability assessment.

Our Technology License Research Package includes:
• Materials: 4Cell® SmartCHO media and feeds, host cell line, and plasmid vials
• Standard protocols and methods from DNA2Pool: gene synthesis, vector cloning, transfection, and pool generation and evaluation
• Add-on protocols and methods (upon request): material production in shake flasks and fed-batch processes in a 50 L rocking motion bioreactor
• Documentation (personalized host cell line history report and TSE | BSE statement for plasmid)
• Proof of concept study, including troubleshooting
• Technical support (remote and on-site upon request)

Please note that the establishment of our CHO cell line development technology at your site is highly flexible. Beyond basic cell culture devices like a flow box, incubator, and shaker, no specific equipment is mandatory for using our CHO cell line development technology. However, certain equipment, such as an electroporator, cell counter, and Octet®, is highly recommended for efficient and successful operation. Workflows and protocols can be adapted to your needs and possibilities.

Please request a quote and contact our CHO cell line development experts to discuss how we can design a tailored project to fit your project and | or product requirements.